866-997-4948(US-Canada Toll Free)

Daewoong Pharmaceutical Co Ltd (069620) - Product Pipeline Analysis, 2018 Uate

Published By :

GlobalData

Published Date : Dec 2018

Category :

Pharmaceutical

No. of Pages : 36 Pages

Summary

Daewoong Pharmaceutical Co Ltd (Daewoong Pharma) is one of the leading manufacturers and distributors of prescription drugs in South Korea. It offers prescription drugs, quasi drugs, medical devices, cosmetics, health foods and APIs. The company produces products in the forms of tablets, capsules, ointments, injections, liquids and sprays. It offers its products for the therapeutic conditions of bone and joint diseases, cardiovascular diseases, central nervous system diseases, circulatory system, dermatological, gastrointestinal, and respiratory remedies, among others. The company also carries out development and commercialization of products through in-licensing, co-marketing and co-promotion. It operates across Asia including Indonesia, China, Vietnam, Thailand and India; and the US. Daewoong Pharma is headquartered in Seoul, South Korea.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Daewoong Pharmaceutical Co Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Daewoong Pharmaceutical Co Ltd Company Overview 5
Daewoong Pharmaceutical Co Ltd Company Snapshot 5
Daewoong Pharmaceutical Co Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Daewoong Pharmaceutical Co Ltd Pipeline Analysis Overview 8
Business Description 8
Daewoong Pharmaceutical Co Ltd - Key Facts 8
Daewoong Pharmaceutical Co Ltd - Major Products and Services 9
Daewoong Pharmaceutical Co Ltd Pipeline Products by Development Stage 11
Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials by Trial Status 13
Daewoong Pharmaceutical Co Ltd Pipeline Products Overview 15
Donepezil Patch 15
Donepezil Patch Product Overview 15
Iodixanol Contrast Medium 16
Iodixanol Contrast Medium Product Overview 16
Ioversol Contrast Medium 17
Ioversol Contrast Medium Product Overview 17
Mediclore 18
Mediclore Product Overview 18
Mediclore Clinical Trial 19
NOVOSIS - DENT 21
NOVOSIS - DENT Product Overview 21
NOVOSIS - Spinal Fusion 22
NOVOSIS - Spinal Fusion Product Overview 22
NOVOSIS - Spinal Fusion Clinical Trial 23
Daewoong Pharmaceutical Co Ltd - Key Competitors 24
Daewoong Pharmaceutical Co Ltd - Key Employees 25
Daewoong Pharmaceutical Co Ltd - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Daewoong Pharmaceutical Co Ltd, Recent Developments 28
May 26, 2016: Daewoong Bio UDCA passes EDQM (European Directorate for the Quality of Medicines & Healthcare) inspection 28
Apr 06, 2016: Daewoong Pharmaceuticals signs export contract and MOU with Taiwanese and Malaysian pharmaceutical companies 28
Dec 14, 2014: Daewoong Pharmaceutical and Daewoong Bio co-participates in CPhI Worldwide 28
Dec 03, 2014: Daewoong Pharmaceuticals Ursa completed registration in Georgia 29
Nov 03, 2014: Daewoong Pharmaceutical established Liaoning Research Institute, its local research arm in China 29
Oct 24, 2014: Lee Jong-wook, President of Daewoong Pharmaceutical, was honored with the grand prize in Korea New Drug Award of Pharmaceutical Society of Korea 30
Sep 30, 2014: Daewoong Pharmaceutical rose to the position of undisputed No. 1 leader in terms of pharmaceutical production last year 30
Sep 24, 2014: Daewoong Pharmaceutical was honored with the Prize of the 'Most Trusted Company in 2014` 31
Mar 18, 2014: Daewoong Pharmaceutical rolls out Easyderm Beauty, the spot-type wet dressing for treating the skin troubles 32
Dec 30, 2011: New-Concept Medical Equipment Novosis Clinical Test Started In Orthopedics In Addition To Dentistry 32
Appendix 33
Methodology 33
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Daewoong Pharmaceutical Co Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Daewoong Pharmaceutical Co Ltd Pipeline Products by Equipment Type 6
Daewoong Pharmaceutical Co Ltd Pipeline Products by Indication 7
Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials by Trial Status 7
Daewoong Pharmaceutical Co Ltd, Key Facts 8
Daewoong Pharmaceutical Co Ltd, Major Products and Services 9
Daewoong Pharmaceutical Co Ltd Number of Pipeline Products by Development Stage 11
Daewoong Pharmaceutical Co Ltd Pipeline Products Summary by Development Stage 12
Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials by Trial Status 13
Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials Summary 14
Donepezil Patch - Product Status 15
Donepezil Patch - Product Description 15
Iodixanol Contrast Medium - Product Status 16
Iodixanol Contrast Medium - Product Description 16
Ioversol Contrast Medium - Product Status 17
Ioversol Contrast Medium - Product Description 17
Mediclore - Product Status 18
Mediclore - Product Description 18
Mediclore - A Randomized, Single-blind, Multi-center, Phase III Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients with Total Thyroidectomy 19
Mediclore - A Randomized, Single-blind, Multi-center, Phase III Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients with Total Thyroidectomy 19
Mediclore - Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore) after Axillary Dissection for Breast Cancer a Multicenter Double-blinded, Randomized Study 19
Mediclore - Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan (Mediclore) for Intraperitoneal Adhesion in Patient with Gynecological Surgery, a Multicenter Single-blinded, Randomized Study 20
Mediclore - To Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore) after Intrauterine Surgery in Patient with Gynecological Disease, a Multicenter, Randomized, Double- blinded Study 20
NOVOSIS - DENT - Product Status 21
NOVOSIS - DENT - Product Description 21
NOVOSIS - Spinal Fusion - Product Status 22
NOVOSIS - Spinal Fusion - Product Description 22
NOVOSIS - Spinal Fusion - The Clinical Study to Evaluate the Efficacy and Safety of Novosis in Posterolateral Fusion 23
Daewoong Pharmaceutical Co Ltd, Key Employees 25
Daewoong Pharmaceutical Co Ltd, Other Locations 26
Daewoong Pharmaceutical Co Ltd, Subsidiaries 27
Glossary 35

List of Figures
Daewoong Pharmaceutical Co Ltd Pipeline Products by Equipment Type 6
Daewoong Pharmaceutical Co Ltd Pipeline Products by Development Stage 11
Daewoong Pharmaceutical Co Ltd Ongoing Clinical Trials by Trial Status 13

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *